Showing results (1-10 of 549) with videos related to
Sort By:
Pageof 55
Current Opinion in Oncology|May 25, 2006
Side effects of anti-cancer molecular-targeted therapies (not monoclonal antibodies)Gilberto de Castro, Ahmad AwadaDrugs & Aging|August 7, 2009
Management of head and neck cancer in elderly patientsYassine Lalami, Gilberto de Castro, Chantal Bernard-Marty, et al.Ecancermedicalscience|January 26, 2019
Precision oncology: as much expectations as limitationsVitor Fiorin Vasconcellos, Leandro Machado Colli, Ahmad Awada, et al.The Oncologist|January 1, 2008
Review: side effects of approved molecular targeted therapies in solid cancersChristian Widakowich, Gilberto de Castro, Evandro de Azambuja, et al.Critical Reviews in Oncology/Hematology|April 8, 2006
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm)Gilberto de Castro Junior, Fabio Puglisi, Evandro de Azambuja, et al.Recenti Progressi in Medicina|May 31, 2014
[Access to cancer care: the cost of treatment matters]Umberto TirelliCurrent Opinion in Oncology|August 12, 2005
Rituximab for HIV-associated lymphoma: weighing the benefits and risksMichele Spina, Umberto TirelliInternal and Emergency Medicine|November 3, 2025
Are new psychoactive substances driving sudden unexpected deaths and violence among youth in the European countries?Umberto Tirelli, Salvatore ChirumboloForum (Genoa, Italy)|March 14, 2003
New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancerAhmad AwadaInternational Journal of Oncology|October 9, 2002
Cancer-related fatigue (review)Marcello Tavio, Isabella Milan, Umberto TirelliPageof 55